Circulating tumor markers: Predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei

作者: Shigeki Kusamura , Ionut Hutanu , Dario Baratti , Marcello Deraco

DOI: 10.1002/JSO.23329

关键词:

摘要: Background Incomplete cytoreduction (IC) is one of the main prognostic factor in pseudomyxoma peritonei (PMP). We evaluated ability preoperative Ca125, CEA, and Ca19-9 to predict IC prognosis PMP. Methods One hundred fifty-six cases elected candidate cytoreductive surgery hyperthermic intraperitoneal chemotherapy from 1996 2011 were included study. assessed the: (1) optimal cut-off values for circulating Tumor markers (CTM) predicting (residual disease >2.5 mm) using receiver-operating characteristics (ROC); (2) discriminant power CTM risk prediction models by calculating area under ROC curve (AUC-ROC); (3) factors Cox proportional-hazard model. Results Optimal cut-offs 125 U/ml 18 ng/ml 89 U/ml Ca19-9. The AUCs-ROC 0.76, 0.68, 0.69 Ca19-9, respectively. addition model that considered clinicopathological increased marginally AUC-ROC (0.80–0.84). Ca125 > 125 U/ml, Ca19-9 > 89 U/ml independently affected overall survival. Conclusions Preoperative CTMs reasonable but not perfect discriminators IC. Moreover, Ca125 new values, proven be strong overcome value extension histological subtype. J. Surg. Oncol. 2013;108:1–8. © 2013 Wiley Periodicals, Inc.

参考文章(30)
Brigite M. Ronnett, Christopher M. Zahn, Robert J. Kurman, Mary E. Kass, Paul H. Sugarbaker, Barry M. Shmookler, Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". The American Journal of Surgical Pathology. ,vol. 19, pp. 1390- 1408 ,(1995) , 10.1097/00000478-199512000-00006
Charles E. Metz, Basic principles of ROC analysis Seminars in Nuclear Medicine. ,vol. 8, pp. 283- 298 ,(1978) , 10.1016/S0001-2998(78)80014-2
A L Farquharson, N Pranesh, G Witham, R Swindell, M B Taylor, A G Renehan, S Rout, M S Wilson, S T O'Dwyer, M P Saunders, A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. British Journal of Cancer. ,vol. 99, pp. 591- 596 ,(2008) , 10.1038/SJ.BJC.6604522
Paul H. Sugarbaker, Lana Bijelic, David Chang, Dal Yoo, Neoadjuvant FOLFOX Chemotherapy in 34 Consecutive Patients With Mucinous Peritoneal Carcinomatosis of Appendiceal Origin Journal of Surgical Oncology. ,vol. 102, pp. 576- 581 ,(2010) , 10.1002/JSO.21679
Haney Youssef, Christopher Newman, Kandiah Chandrakumaran, Faheez Mohamed, Tom D. Cecil, Brendan J. Moran, Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Diseases of The Colon & Rectum. ,vol. 54, pp. 293- 299 ,(2011) , 10.1007/DCR.0B013E318202F026
Patrick L. Wagner, Frances Austin, Magesh Sathaiah, Deepa Magge, Ugwuji Maduekwe, Lekshmi Ramalingam, Heather L. Jones, Matthew P. Holtzman, Steven A. Ahrendt, Amer H. Zureikat, James F. Pingpank, Herbert J. Zeh, David L. Bartlett, Haroon A. Choudry, Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin Annals of Surgical Oncology. ,vol. 20, pp. 506- 514 ,(2013) , 10.1245/S10434-012-2627-5
D. Baratti, A. Scivales, M.R. Balestra, P. Ponzi, F. Di Stasi, S. Kusamura, B. Laterza, M. Deraco, Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ejso. ,vol. 36, pp. 463- 469 ,(2010) , 10.1016/J.EJSO.2010.03.005
Paul H. Sugarbaker, David Chang, Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Annals of Surgical Oncology. ,vol. 6, pp. 727- 731 ,(1999) , 10.1007/S10434-999-0727-7
Armin Quentmeier, Peter Möller, Volker Schwarz, Ulrich Abel, Peter Schlag, Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue. Cancer. ,vol. 60, pp. 2261- 2266 ,(1987) , 10.1002/1097-0142(19871101)60:9<2261::AID-CNCR2820600926>3.0.CO;2-P
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8